Novavax COVID-19 vaccine, adjuvanted – Expanded emergency use authorization
August 19, 2022 - The FDA announced the emergency use authorization (EUA) of the Novavax COVID-19 vaccine, adjuvanted, for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older.
Top